Twin Health, known for its innovative Digital Twin™ AI platform, has announced encouraging findings from a recent study focused on hypertension in patients with type 2 diabetes. The study, published in the Journal of the American College of Cardiology, highlights how the platform can effectively help users manage blood pressure and reduce their dependence on medication.
The Connection Between Diabetes And Hypertension
High blood pressure often accompanies type 2 diabetes, with approximately 74% of individuals experiencing hypertension or needing medication to control it. This combination significantly raises the risk of serious cardiovascular issues, including heart attacks, strokes, and vision loss. While lifestyle changes can help manage both conditions, many patients still rely on multiple medications. Twin Health aims to address these underlying metabolic issues with its Digital Twin™ technology.
Key Findings From The Study
The recent study analyzed data from a one-year randomized controlled trial involving 59 patients with type 2 diabetes who were also taking medication for high blood pressure. Results showed that those using the Digital Twin™ AI platform achieved a much higher rate of normalized blood pressure compared to the control group—40.9% versus just 6.7%.
How Digital Twin™ Technology Works
The Digital Twin™ platform creates a personalized AI model of each member’s metabolism. By continuously collecting and analyzing data from wearable sensors and other sources, the platform offers tailored recommendations to help users adopt healthier habits.
Members can access real-time insights through an easy-to-use app, which covers areas such as nutrition, sleep, activity, and stress management. They also receive ongoing support from a dedicated care team, empowering them to make sustainable lifestyle changes that target the root causes of their metabolic conditions.
Dr. Jeff Mechanick, lead author of the study and Medical Director at Mount Sinai Fuster Heart Hospital in New York City, commented on the significance of these findings. “The impact of these results is not confined to just lowering blood pressure and blood sugar levels,” he said. “They also address critical drivers of chronic metabolic disease, shifting focus from costly polypharmacy to sustainable and effective lifestyle changes.”
The Future of Metabolic Health Management
Twin Health’s approach represents a shift in how metabolic diseases are managed. By focusing on personalized care and addressing the root causes of conditions like type 2 diabetes and hypertension, the Digital Twin™ platform aims to improve patient outcomes while reducing reliance on medications.
As more studies emerge showcasing the effectiveness of this technology, Twin Health is poised to play a significant role in transforming how individuals manage their health and well-being.
Related topics:
- Glenmark And API Launch “Take Charge @18” Campaign for Early Hypertension Screening
- New Insights on Hypertension And Its Link to Dementia
- Korea Expands Chronic Disease Management to Reduce Costs for Hypertension And Diabetes